Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| CTEV | CLARITEV CORP | $279.58M | 16,552,723 | 13.76% | 86.24% | Net Selling | Net Selling | ||
| CLFD | CLEARFIELD INC | $389.35M | 13,685,411 | 60.37% | 39.63% | Net Buying | Net Selling | ||
| LION | LIONSGATE STUDIOS CORP | $2.82B | 290,187,242 | 86.16% | 6.03% | Net Selling | Net Selling | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $209.10M | 56,284,083 | 65.34% | 0.00% | ||||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.50B | 76,535,377 | 65.27% | 9.27% | Net Selling | Net Selling | ||
| RLMD | RELMADA THERAPEUTICS INC | $433.40M | 73,333,622 | 70.41% | 4.82% | Net Buying | |||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $517.77M | 243,085,387 | 31.30% | 0.00% | ||||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $7.71B | 140,032,190 | 82.92% | 9.84% | Net Selling | Net Selling | ||
| SLDB | SOLID BIOSCIENCES INC | $569.52M | 77,910,239 | 55.24% | 44.76% | Net Selling | Net Selling | ||
| PCVX | VAXCYTE INC | $7.86B | 143,920,361 | 88.01% | 11.99% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $816.50M | 60,526,128 | 56.33% | 43.67% | Net Buying | Net Selling | ||
| MITT | TPG MORTGAGE INVESTMENT TRUST INC | $236.11M | 31,735,457 | 37.75% | 7.39% | Net Selling | Net Selling | ||
| DMRA | DAMORA THERAPEUTICS INC | $34.95M | 1,327,212 | 6.48% | 93.52% | Net Selling | Net Selling | ||
| ONC | BEONE MEDICINES LTD | $31.54B | 1,442,259,810 | 2.35% | 32.03% | Net Buying | Net Buying | ||
| GIL | GILDAN ACTIVEWEAR INC | $10.86B | 185,152,443 | 78.57% | 0.00% | ||||
| VKTX | VIKING THERAPEUTICS INC | $4.12B | 115,554,295 | 62.25% | 8.90% | Net Selling | Net Selling | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $1.01B | 68,659,923 | 78.20% | 21.80% | Net Selling | Net Selling | ||
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | $727.50M | 80,032,823 | 63.11% | 36.89% | Net Buying | |||
| TRVI | TREVI THERAPEUTICS INC | $1.41B | 128,230,134 | 43.05% | 56.95% | Net Buying | |||
| CRVS | CORVUS PHARMACEUTICALS INC | $1.29B | 83,992,407 | 55.58% | 38.94% | Net Buying | Net Buying | ||
| NTSK | NETSKOPE INC | $3.83B | 393,258,861 | 34.74% | 11.96% | Net Buying | Net Selling | ||
| IKT | INHIBIKASE THERAPEUTICS INC | $150.35M | 75,175,306 | 83.08% | 16.92% | Net Buying | |||
| MPLT | MAPLIGHT THERAPEUTICS INC | $865.26M | 45,373,033 | 45.71% | 54.29% | Net Buying | Net Selling | ||
| TLX | TELIX PHARMACEUTICALS LTD | $2.66B | 338,777,049 | 0.33% | 0.00% | ||||
| RACE | FERRARI NV | $58.83B | 177,278,893 | 33.89% | 0.00% | ||||
| GLOO | GLOO HOLDINGS INC | $478.99M | 79,698,784 | 4.59% | 7.90% | Net Buying | |||
| TTAN | SERVICETITAN INC | $6.63B | 93,646,634 | 46.57% | 53.43% | Net Selling | Net Selling | ||
| FLR | FLUOR CORP | $6.31B | 146,564,673 | 94.43% | 4.03% | Net Selling | Net Selling | ||
| IPHA | INNATE PHARMA SA | $130.41M | 86,937,000 | 0.32% | 0.00% | ||||
| ARVN | ARVINAS INC | $779.04M | 63,960,997 | 70.82% | 29.18% | Net Selling | Net Selling | ||
| PAR | PAR TECHNOLOGY CORP | $607.82M | 41,152,632 | 77.04% | 22.96% | Net Buying | Net Buying | ||
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $2.13B | 348,999,320 | 0.01% | 0.00% | ||||
| CRVO | CERVOMED INC | $39.35M | 9,258,719 | 3.05% | 96.95% | Net Buying | |||
| RZLT | REZOLUTE INC | $248.34M | 95,697,685 | 45.59% | 54.41% | Net Buying | Net Selling | ||
| SYNA | SYNAPTICS INC | $2.86B | 38,729,741 | 93.62% | 6.38% | Net Selling | Net Selling | ||
| OFIX | ORTHOFIX MEDICAL INC | $469.69M | 40,144,397 | 77.02% | 22.98% | Net Buying | Net Buying | ||
| KYTX | KYVERNA THERAPEUTICS INC | $391.98M | 43,796,170 | 53.78% | 46.22% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.